Business Description
Clearside Biomedical Inc
NAICS : 325412
SIC : 2834
ISIN : US1850631045
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 34.02 | |||||
Equity-to-Asset | -0.83 | |||||
Debt-to-Equity | -0.03 | |||||
Debt-to-EBITDA | -0.04 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | -14.46 | |||||
Beneish M-Score | -2.27 | |||||
WACC vs ROIC |
Growth Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -7.9 | |||||
3-Year EBITDA Growth Rate | 1.3 | |||||
3-Year EPS without NRI Growth Rate | -10.8 | |||||
3-Year FCF Growth Rate | -4.4 |
Momentum Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 30.32 | |||||
9-Day RSI | 39.05 | |||||
14-Day RSI | 43.9 | |||||
6-1 Month Momentum % | -1.71 | |||||
12-1 Month Momentum % | 44.65 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 5.07 | |||||
Quick Ratio | 5.07 | |||||
Cash Ratio | 5 | |||||
Days Sales Outstanding | 21.13 | |||||
Days Payable | 4573.81 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -6.6 | |||||
Shareholder Yield % | -17.77 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 98.11 | |||||
Operating Margin % | -342.48 | |||||
Net Margin % | -444.66 | |||||
FCF Margin % | -270.41 | |||||
ROA % | -92.06 | |||||
ROIC % | -474.25 | |||||
ROC (Joel Greenblatt) % | -639.44 | |||||
ROCE % | -78.36 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 9.58 | |||||
EV-to-EBIT | -2.41 | |||||
EV-to-EBITDA | -2.42 | |||||
EV-to-Revenue | 7.64 | |||||
EV-to-Forward-Revenue | 65.41 | |||||
EV-to-FCF | -2.85 | |||||
Earnings Yield (Greenblatt) % | -41.49 | |||||
FCF Yield % | -23.45 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Clearside Biomedical Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 6.919 | ||
EPS (TTM) (€) | -0.463 | ||
Beta | 2.24 | ||
Volatility % | 68.04 | ||
14-Day RSI | 43.9 | ||
14-Day ATR (€) | 0.054792 | ||
20-Day SMA (€) | 1.1385 | ||
12-1 Month Momentum % | 44.65 | ||
52-Week Range (€) | 0.625 - 1.92 | ||
Shares Outstanding (Mil) | 74.75 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Clearside Biomedical Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Clearside Biomedical Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Clearside Biomedical Inc Frequently Asked Questions
What is Clearside Biomedical Inc(FRA:CLM)'s stock price today?
When is next earnings date of Clearside Biomedical Inc(FRA:CLM)?
Does Clearside Biomedical Inc(FRA:CLM) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |